Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
8.0
232.07%
80%
—
111x
Every year
—
5 Years
Score8.0
Net Growth232.07%
Net Trend80%
Net Income Consistency—
Rev Growth111x
Rev TrendEvery year
Revenue Consistency—
Ascendis Pharma AS fundamental performance
Between 2020 and 2025, revenue grew from € 6M to € 691M and net income went from -€ 418M to -€ 219M. Revenue increased in every one of those 5 years; net income in 4.
Between 2015 and 2025, revenue grew from € 8M to € 691M and net income went from -€ 32M to -€ 219M. Revenue increased in 8 of those 10 years; net income in 5.
Ascendis Pharma AS currently holds a 5-year HDB Score of 8.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 255.46 | — |
1 Year2025-08-12 | $ 195.98 | 30.35% |
5 Years2021-08-12 | $ 120.53 | 111.95% |
10 Years2016-08-12 | $ 15.11 | 16x |
All Time2015-01-28 | $ 18.83 | 13x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-01-28 |
|---|---|---|---|---|---|
| Price | $ 255.46 | $ 195.98 | $ 120.53 | $ 15.11 | $ 18.83 |
| Return | — | 30.35% | 111.95% | 16x | 13x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | € 867M | € 506M | € 573M |
| 2025 | € 691M | -€ 219M | € 615M |
| 2024 | € 363M | -€ 378M | € 559M |
| 2023 | € 266M | -€ 481M | € 399M |
| 2022 | € 51M | -€ 583M | € 735M |
| 2021 | € 7M | -€ 383M | € 682M |
| 2020 | € 6M | -€ 418M | € 718M |
| 2019 | € 13M | -€ 218M | € 598M |
| 2018 | € 10M | -€ 130M | € 277M |
| 2017 | € 1M | -€ 123M | € 195M |
| 2016 | € 4M | -€ 68M | € 180M |
| IPO2015 | € 8M | -€ 32M | € 119M |
Explore beyond ASND
You're looking at Ascendis Pharma AS. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
